The trial is assessing the therapy for individuals with ischemic heart failure of minimised ejection fraction.

My role is to ensure they can transition seamlessly from clinic to classroom, allowing them to focus on what truly matters: ...

CardiAMP HF II is Evaluating the CardiAMP™ Cell Therapy Product for Treating Patients with Ischemic Heart Failure of Reduced Ejection Fraction ...

and assistant professor in the Department of Pediatrics at Emory University School of Medicine. For this study, Qiu also developed the hydrogel for this model using human blood in a human vein, making ...

Immigration and Customs Enforcement (ICE) recently forcibly restrained and arrested a Tufts University (Mass.) doctoral ...

For the third straight year, the U.S. News & World Report (USNWR) ranked Emory University’s Nell Hodgson Woodruff School of Nursing master’s program as No. 1. On April 8, USNWR released its rankings ...

BioCardia (BCDA) announced that Emory University School of Medicine in Atlanta Georgia is now enrolling patients with ischemic heart failure in ...

SUNNYVALE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary ...

Department of Medicine, Emory University School of Medicine, and Co-Director of the Emory Clinical Cardiovascular Research Institute to Serve as Principal Investigator SUNNYVALE, Calif., ...